Early Outcomes of the Evolut R Transcatheter Aortic Valve: A New Technology Between Achieved Goals and Desirable Improvements

Affiliations

Free article

Editorial

Marco Barbanti. JACC Cardiovasc Interv. 2017.

Free article

. 2017 Feb 13;10(3):283-285.

doi: 10.1016/j.jcin.2016.12.029.

¹ Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy. Electronic address: mbarbanti83@gmail.com.

No abstract available

Keywords: TAVR; aortic stenosis; new devices.

Comment on

Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.
Popma JJ, Reardon MJ, Khabbaz K, Harrison JK, Hughes GC, Kodali S, George I, Deeb GM, Chetcuti S, Kipperman R, Brown J, Qiao H, Slater J, Williams MR. Popma JJ, et al. JACC Cardiovasc Interv. 2017 Feb 13;10(3):268-275. doi: 10.1016/j.jcin.2016.08.050. JACC Cardiovasc Interv. 2017. PMID: 28183466 Clinical Trial.
Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
Kalra SS, Firoozi S, Yeh J, Blackman DJ, Rashid S, Davies S, Moat N, Dalby M, Kabir T, Khogali SS, Anderson RA, Groves PH, Mylotte D, Hildick-Smith D, Rampat R, Kovac J, Gunarathne A, Laborde JC, Brecker SJ. Kalra SS, et al. JACC Cardiovasc Interv. 2017 Feb 13;10(3):276-282. doi: 10.1016/j.jcin.2016.11.025. JACC Cardiovasc Interv. 2017. PMID: 28183467